ArrePath Company Profile: Funding, Investors & Partnerships

ArrePath

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. The company’s proprietary machine learning (ML)-based platform enables the rapid and efficient identification of anti-infective agents with new mechanisms of action at the outset of the discovery process, through a deep understanding and analysis of pathogen behavior.ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug Show More

Alpha Score

56.9

Total Funding$ 21.27 M